当前位置:首页 - 行情中心 - 迈克生物(300463) - 财务分析 - 现金流量表

迈克生物

(300463)

  

流通市值:60.70亿  总市值:75.64亿
流通股本:4.92亿   总股本:6.12亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金2,248,945,422.621,468,855,373.91736,740,132.553,430,504,496.21
收到的税费返还36,049,781.6225,854,477.9721,428,623.4192,084,539.51
收到其他与经营活动有关的现金19,103,374.8912,496,661.197,675,986.9631,082,323.1
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,304,098,579.131,507,206,513.07765,844,742.923,553,671,358.82
购买商品、接受劳务支付的现金975,379,952.65711,102,071438,486,938.761,460,371,506.88
支付给职工以及为职工支付的现金402,215,786.89283,207,005.34172,434,047.67506,458,379.44
支付的各项税费143,095,869.83105,852,361.0948,756,694.41229,460,157.29
支付其他与经营活动有关的现金290,407,580.12194,364,828.42101,282,774.42455,871,193.22
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,811,099,189.491,294,526,265.85760,960,455.262,652,161,236.83
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额492,999,389.64212,680,247.224,884,287.66901,510,121.99
二、投资活动产生的现金流量:
收回投资收到的现金590,000,000450,000,000310,000,0002,125,194,226.61
取得投资收益收到的现金3,596,631.792,806,187.961,961,240.0110,578,413.81
处置固定资产、无形资产和其他长期资产收回的现金净额5,023,406.67553,006.675,86018,176,950.16
投资活动现金流入的平衡项目0000
投资活动现金流入小计598,620,038.46453,359,194.63311,967,100.012,153,949,590.58
购建固定资产、无形资产和其他长期资产支付的现金738,860,856.72464,566,336.5211,428,278.87877,904,821.86
投资支付的现金400,000,000280,000,000140,000,0001,770,400,000
支付其他与投资活动有关的现金---8,687,713.57
投资活动现金流出的平衡项目0000
投资活动现金流出小计1,138,860,856.72744,566,336.5351,428,278.872,656,992,535.43
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-540,240,818.26-291,207,141.87-39,461,178.86-503,042,944.85
三、筹资活动产生的现金流量:
取得借款收到的现金580,793,037.56466,622,463.08134,152,157.14608,746,870.84
收到其他与筹资活动有关的现金-2,612,073.76--
筹资活动现金流入平衡项目0000
筹资活动现金流入小计580,793,037.56469,234,536.84134,152,157.14608,746,870.84
偿还债务支付的现金408,072,495.27257,558,034.1286,651,695.17495,020,930.96
分配股利、利润或偿付利息支付的现金110,054,926.5210,601,771.625,357,192.9247,162,011.4
其中:子公司支付给少数股东的股利、利润---2,519,500
支付其他与筹资活动有关的现金18,699,944.245,063,060.525,977,243.5719,314,510.22
筹资活动现金流出平衡项目0000
筹资活动现金流出小计536,827,366.03273,222,866.24117,986,131.64761,497,452.58
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额43,965,671.53196,011,670.616,166,025.5-152,750,581.74
四、汇率变动对现金及现金等价物的影响-2,028,700.86216,989.67167,453.921,352,665.95
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-5,304,457.95117,701,765.62-18,243,411.78247,069,261.35
加:期初现金及现金等价物余额811,362,294.43811,362,294.43811,362,294.43564,293,033.08
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额806,057,836.48929,064,060.05793,118,882.65811,362,294.43
补充资料:
净利润-202,489,859.89-304,679,076.7
资产减值准备--10,610,085.21-94,409,973.72
固定资产和投资性房地产折旧-116,967,250.11-244,555,706.48
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-116,967,250.11-244,555,706.48
无形资产摊销-19,533,399.59-50,384,773.36
长期待摊费用摊销-1,078,589.21-4,739,843.84
处置固定资产、无形资产和其他长期资产的损失-3,429,889.27-4,165,350.13
固定资产报废损失-2,307,705.51-9,543,728.49
公允价值变动损失-2,221,009.33-7,076,745.18
财务费用-11,675,822.03-32,423,042.1
投资损失--2,647,347.14--8,592,386.93
递延所得税-4,966,963.42--34,308,398.91
其中:递延所得税资产减少-7,189,480.78-3,512,476.22
递延所得税负债增加--2,222,517.36--37,820,875.13
存货的减少--74,464,151.94-11,092,073.59
经营性应收项目的减少-94,978,635.47-214,656,871.12
经营性应付项目的增加--167,095,567.5--51,458,427.31
现金的期末余额-929,064,060.05-811,362,294.43
减:现金的期初余额-811,362,294.43-564,293,033.08
公告日期2024-10-232024-08-022024-04-252024-04-25
审计意见(境内)标准无保留意见
TOP↑